Lung Cancer Treatment Cyramza (Ramucirumab) is an approved drug for the treatment of non-small cell lung cancer (NSCLC). It was approved by US FDA as a single agent for treatment of patients…
Month: February 2017
Drug: Crizotinib for Lung Cancer
Crizotinib FDA Approved Among cancer-related deaths in the United States, lung cancer is the leading cause. FDA has approved the use of Xalkori (crizotinib) for treating patients with non-small cell lung cancer…
Drug: Ceritinib to Treat NSCLC
Ceritinib for Lung Cancer Treatment Ceritinib is a drug for the treatment of lung cancer. It is the generic for the trade chemotherapy drug Zykadia. The drug is a prescription medicine to…
Drug: Avastin (Bevacizumab) to Treat NSCLC
Avastin for Lung Cancer Avastin (Bevacizumab) is a cancer medicine that works to stop the growth and spread of cancer cells. It is used to treat certain types of cancers such as…